Align Strategy team working on late lifecycle management

Sustain Value in the Late Lifecycle

Loss of exclusivity (LOE) doesn’t have to mean loss of impact. With the right late lifecycle management, pharmaceutical teams can navigate a transforming competitive landscape, protect brand relevance, and execute their strategy with confidence across diverse markets.

Loss of Exclusivity Isn’t the End For Your Brand, But Failing to Plan For It Could Be

Late lifecycle planning often starts too late, becomes fragmented across teams, or relies on strategies designed for earlier – and simpler – stages of the lifecycle. The result is missed opportunities, misaligned investment, and brands that lose impact faster than they should. From same-molecule competitors to increasingly complex market dynamics, the drivers of decision-making post-LOE have unquestionably changed. For unprepared teams, this can mark the start of a rapid decline.

However, with early planning, a clear strategic direction, and strong global‑to‑local alignment, you can continue to deliver meaningful value well beyond loss of exclusivity. That’s where Align Strategy comes in.

 

A graph showing increased value with effective late lifecycle management

Transforming Late Lifecycle Management

Building a global late lifecycle management strategy

Build Global Strategy with Local Resonance

Following loss of exclusivity, your existing global strategy is no longer enough. Value is now shaped locally across increasingly diverse markets. Global strategy is not dead, but it has fundamentally changed.

We help you embrace this evolution quickly, moving from global control tower to local value enabler – delivering clarity, not constraint. With Align’s support, global teams build insight-led strategies that empower local teams while maintaining coherence across increasingly complex post-LOE environments.

Aligning late lifecycle management

Escape Planning Silos and Align Across Teams

The late lifecycle often exposes cracks in how organizations plan. As LOE approaches, responsibilities fragment, timelines diverge, and global, regional, and local teams find themselves out of sync.

Drawing on deep experience across functions and geographies, we bring structure and cohesion to late lifecycle planning. From commercial to legal, we help your teams align around a shared understanding of post‑LOE dynamics and their implications. The result is less duplication, faster decision‑making, and greater strategic impact.

Executing local late lifecycle plans

Equip Every Market to Execute with Confidence

In late lifecycle management, success is ultimately determined at the local level – by how effectively strategy translates into action across a wide variety of rapidly changing markets.

That’s why we equip local teams with the tools and guidance to make better decisions in complex, resource‑constrained environments. With Align Strategy providing clear strategic direction, practical planning frameworks, and deep local insight, teams are empowered to develop robust, globally aligned local plans – and execute them with confidence.

We Are Experts in Late Lifecycle Management

A proven track record of helping pharmaceutical teams succeed beyond loss of exclusivity.

  • 70+ LLC projects in last 5 years

  • 30+ Local markets supported

  • 15+ Years delivering LLC training

Why Align Strategy?

  • Deep Understanding

    We offer a deep understanding of LOE dynamics in a diverse range of global markets, and broad experience in building LLC plans across them.

  • Alignment Specialists

    Proven facilitators of cross-functional teams looking to identify, assess, and implement tactical options that deliver highly effective LLC planning.

  • Patient-Centric Approach

    Our support and guidance puts patient centricity at the heart of a late lifecycle strategy, promoting a sustainable and competitive landscape.

  • Impactful Tools & Frameworks

    Over many years we have built a library of proprietary late lifecycle management frameworks and tools with tried-and-tested real-world application and impact.

A Closer Look at Our Late LCM Programs

Late Lifecycle Offering

Objective

Our Solution

Objective

End‑to‑End Late Lifecycle Support

A cohesive, insight‑led late lifecycle management approach that connects global strategy with confident local execution - enabling sustained patient and commercial value across diverse post‑LOE environments.

Our Solution

Building a Global Strategic Blueprint

We help global teams define a clear late lifecycle strategy grounded in how post‑LOE dynamics are expected to evolve across markets, aligning stakeholders around a shared direction and long‑range tactical priorities.

Translating Global to Local

As post‑LOE environments diverge, we enable global intent to flex without fragmenting - using practical frameworks, archetyping, and governance to support consistent, high‑quality local planning.

Supporting Local Late Lifecycle Plans

We support regional and local teams to develop robust plans and business cases that reflect local realities while remaining globally aligned, pressure‑tested for feasibility, impact, and confidence.

Objective

Leave No Stone Unturned

An independent assessment of your existing late lifecycle strategy or plans, designed to identify gaps, strengthen alignment, and improve execution readiness ahead of LOE.

Our Solution

Audit of LLC Materials

Thorough review of all existing lifecycle management plans and materials to establish understanding of the existing late-lifecycle plans.

Interview Internal Stakeholders

In-depth interviews with cross-functional colleagues involved in LLC planning to further develop understanding and established context for existing plans.

Develop Strategic Recommendations

Development of a comprehensive report with targeted recommendations for LLC plan optimization and proposed next steps to ensure effective integration.

Objective

Bring Teams Up to Speed

Tailored training programs that equip teams with a detailed view of LOE dynamics and practical tools for effective late lifecycle planning, supported by real‑world case studies and application to your brand or portfolio.

Our Solution

Shaping Understanding

We give your team a clear understanding of the key dynamics of LOE that influenceyour approach to late lifecycle management.

Instilling Inspiration

An introduction to practical tools and tactics for building effectiveLLC plans, supported by real-world case studies.

Guiding Application

Support in translating the theory of LLCM into practical application for your team's brand or portfolio strategy development.

Start the conversation

Do Your LLC Plans Need a Second Opinion?

Whether you’re in early-stage planning or already have a strategy in place, an independent perspective can make the difference between decline and sustained value.

Our specialists will pressure-test your approach, identify critical gaps, and provide clear, actionable recommendations that elevate your lifecycle approach, strengthen alignment, and streamline implementation.

Don’t wait until it’s too late – get in touch to learn more about a strategic health check today.

Key Expertise In Late Lifecycle Strategy

We bring decades of experience shaping late lifecycle strategy, with deep expertise in helping teams navigate loss of exclusivity.

Neal Hansen, PhD

Managing Director

As co-founder of Align Strategy, Neal brings over 20 years of experience advising leading pharmaceutical and biotech firms on lifecycle management and brand strategy.

Qualifications

PhD, Pharmacology (University of Cambridge)

MA (Hons), Natural Sciences (University of Cambridge)

James Kettlewell

Principal Consultant

James, with nearly 10 years in healthcare, specializes in shaping strategic direction through product and market assessments.

Qualifications

MSc, Drug Discovery & Translational Biology (University of Edinburgh)

BSc (Hons), Cell Biology (University of St Andrews)

AlignOn Late Lifecycle Management Insights

Lifecycle Management

5 Best Practices In Late Lifecycle Management

Navigate brand challenges with tailored Lifecycle Management. Explore 5 key practices for success as your portfolio evolves.

Brand and Portfolio Planning

Navigating the Late Lifecycle: Transitioning Away From the Global Brand Plan

Explore a strategic shift in Late-Lifecycle with our insights. Is the global brand plan effective as your brand approaches maturity? Navigate change for sustained success.

Lifecycle Management

Six Strategy Decision Points for Effective Lifecycle Management

Maximize pharma asset value with our infographic: Six Strategic Decision Points for balanced Lifecycle Management success.

Your partner for loss of exclusivity and beyond

Speak with one of our late lifecycle experts today to learn more.